Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma. - Lauer UM; Awada A; Postel-Vinay S; Shapiro GI; Thieblemont C; Piha-Paul SA; Paik PK; Shepard DR; Docampo LI; Galot R; Rottey S; Sadrolhefazi B; et al. (ESMO open, 2025)